Fabrice Denis

Summary

Country: France

Publications

  1. ncbi [Prognostic value of the number of involved nodes after neck dissection in oropharyngeal and oral cavity carcinoma]
    F Denis
    Clinique d Oncologie et de Radiothérapie, Centre Hospitalier Universitaire, 37044 Tours, France
    Cancer Radiother 5:12-22. 2001
  2. ncbi [Anaemia and radiation therapy]
    F Denis
    Clinique d Oncologie et de Radiothérapie, INSERM U619, CHU, 37044 Tours, France
    Cancer Radiother 8:S14-23. 2004
  3. ncbi Contrast enhanced magnetic resonance imaging underestimates residual disease following neoadjuvant docetaxel based chemotherapy for breast cancer
    F Denis
    Clinique d Oncologie Radiothérapie, Tours, France
    Eur J Surg Oncol 30:1069-76. 2004
  4. ncbi Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma
    Fabrice Denis
    Clinique d Oncologie et Radiothérapie, Hopital Bretonneau, 2 Blvd Tonnelé, 37044 Tours, France
    J Clin Oncol 22:69-76. 2004
  5. ncbi Changes in tumor vascularization after irradiation, anthracyclin, or antiangiogenic treatment in nitrosomethyl ureas-induced rat mammary tumors
    Fabrice Denis
    Institut National de la Santé et de la Recherche Médicale E 0211, Tours, France
    Clin Cancer Res 9:4546-52. 2003
  6. ncbi Radiosensitivity of rat mammary tumors correlates with early vessel changes assessed by power Doppler sonography
    Fabrice Denis
    Institut National de la Santé et de la Recherche Médicale E 0211, CORAD, Centre Hospitalier Universitaire Bretonneau, 37044 Tours France
    J Ultrasound Med 22:921-9. 2003
  7. ncbi Late toxicity results of the GORTEC 94-01 randomized trial comparing radiotherapy with concomitant radiochemotherapy for advanced-stage oropharynx carcinoma: comparison of LENT/SOMA, RTOG/EORTC, and NCI-CTC scoring systems
    Fabrice Denis
    Clinique d Oncologie et de Radiothérapie, Centre Hospitalier Universitaire, Tours, France
    Int J Radiat Oncol Biol Phys 55:93-8. 2003
  8. ncbi Enhanced radiosensitivity of rat autochthonous mammary tumors by dietary docosahexaenoic acid
    Séverine Colas
    Nutrition Croissance et Cancer, INSERM E 0211, IFR 120, CHU Bretonneau, Tours, France
    Int J Cancer 109:449-54. 2004
  9. ncbi In vivo quantitation of tumour vascularisation assessed by Doppler sonography in rat mammary tumours
    Fabrice Denis
    Laboratoire Nutrition, Croissance et Cancer, UPRES EA 2103, Universite Francois Rabelais, 37044 Tours, France
    Ultrasound Med Biol 28:431-7. 2002
  10. pmc Relationship between 5-fluorouracil exposure and outcome in patients receiving continuous venous infusion with or without concomitant radiotherapy
    Maud Beneton
    Department of Pharmacology, CHRU de Tours, Tours, France
    Br J Clin Pharmacol 64:613-21. 2007

Collaborators

Detail Information

Publications11

  1. ncbi [Prognostic value of the number of involved nodes after neck dissection in oropharyngeal and oral cavity carcinoma]
    F Denis
    Clinique d Oncologie et de Radiothérapie, Centre Hospitalier Universitaire, 37044 Tours, France
    Cancer Radiother 5:12-22. 2001
    ..To evaluate the relationship between the number of positive nodes and probabilities of locoregional control and survival in patients with invasive squamous cell carcinomas of the oral cavity and oropharynx...
  2. ncbi [Anaemia and radiation therapy]
    F Denis
    Clinique d Oncologie et de Radiothérapie, INSERM U619, CHU, 37044 Tours, France
    Cancer Radiother 8:S14-23. 2004
    ..The results of recent clinical trials suggest that using erythropoietin should be avoided in non-anemic patients and discussed in patients receiving curative therapy...
  3. ncbi Contrast enhanced magnetic resonance imaging underestimates residual disease following neoadjuvant docetaxel based chemotherapy for breast cancer
    F Denis
    Clinique d Oncologie Radiothérapie, Tours, France
    Eur J Surg Oncol 30:1069-76. 2004
    ..We prospectively compared the ability of magnetic resonance imaging (MRI) to measure residual breast cancer in patients treated with different neoadjuvant chemotherapy regimen...
  4. ncbi Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma
    Fabrice Denis
    Clinique d Oncologie et Radiothérapie, Hopital Bretonneau, 2 Blvd Tonnelé, 37044 Tours, France
    J Clin Oncol 22:69-76. 2004
    ....
  5. ncbi Changes in tumor vascularization after irradiation, anthracyclin, or antiangiogenic treatment in nitrosomethyl ureas-induced rat mammary tumors
    Fabrice Denis
    Institut National de la Santé et de la Recherche Médicale E 0211, Tours, France
    Clin Cancer Res 9:4546-52. 2003
    ....
  6. ncbi Radiosensitivity of rat mammary tumors correlates with early vessel changes assessed by power Doppler sonography
    Fabrice Denis
    Institut National de la Santé et de la Recherche Médicale E 0211, CORAD, Centre Hospitalier Universitaire Bretonneau, 37044 Tours France
    J Ultrasound Med 22:921-9. 2003
    ..To investigate the changes occurring in the vascularization of tumors during irradiation, we used a model of autochthonous mammary tumors in rats and assessed early vascular changes after irradiation by power Doppler sonography...
  7. ncbi Late toxicity results of the GORTEC 94-01 randomized trial comparing radiotherapy with concomitant radiochemotherapy for advanced-stage oropharynx carcinoma: comparison of LENT/SOMA, RTOG/EORTC, and NCI-CTC scoring systems
    Fabrice Denis
    Clinique d Oncologie et de Radiothérapie, Centre Hospitalier Universitaire, Tours, France
    Int J Radiat Oncol Biol Phys 55:93-8. 2003
    ..To prospectively assess 5-year late toxicity in patients treated by concomitant radiochemotherapy for locally advanced oropharynx carcinoma using three different toxicity scales...
  8. ncbi Enhanced radiosensitivity of rat autochthonous mammary tumors by dietary docosahexaenoic acid
    Séverine Colas
    Nutrition Croissance et Cancer, INSERM E 0211, IFR 120, CHU Bretonneau, Tours, France
    Int J Cancer 109:449-54. 2004
    ..Therefore, dietary DHA sensitized mammary tumors to radiation. The addition of vitamin E inhibited the beneficial effect of DHA, suggesting that this effect might be mediated by oxidative damage to the peroxidizable lipids...
  9. ncbi In vivo quantitation of tumour vascularisation assessed by Doppler sonography in rat mammary tumours
    Fabrice Denis
    Laboratoire Nutrition, Croissance et Cancer, UPRES EA 2103, Universite Francois Rabelais, 37044 Tours, France
    Ultrasound Med Biol 28:431-7. 2002
    ..The monitoring of angiogenesis according to different treatments is feasible in real-time. Further studies are needed to investigate the predictive value of CPD and VI on sensitivity of mammary tumours to anticancer treatment...
  10. pmc Relationship between 5-fluorouracil exposure and outcome in patients receiving continuous venous infusion with or without concomitant radiotherapy
    Maud Beneton
    Department of Pharmacology, CHRU de Tours, Tours, France
    Br J Clin Pharmacol 64:613-21. 2007
    ..We investigated the plasma concentration-effect relationship for this regimen, with the aim of developing recommendations for dose adjustment...
  11. ncbi Sensitization by dietary docosahexaenoic acid of rat mammary carcinoma to anthracycline: a role for tumor vascularization
    Séverine Colas
    Institut National de la Sante et de la Recherche Medicale, E0211 Nutrition Croissance et Cancer, CHU Bretonneau, 2 bis Boulevard Tonnelle, F 37044 Tours, France
    Clin Cancer Res 12:5879-86. 2006
    ....